MAINTENANCE NOTIFICATION: There is a scheduled maintenance that will result in intermittent service interruption between 2pm and 5pm EST on Friday, April 3rd 2020
Menu
Search
Home > Courses > Prevention and Early Detection of HPV-associated Anogenital Cancers in Women Living with HIV

Prevention and Early Detection of HPV-associated Anogenital Cancers in Women Living with HIV

Prevention and Early Detection of HPV-associated Anogenital Cancers in Women Living with HIV
Play
Sorry, this learning module is not available for mobile devices.
Original Release Date: 10/15/2019
Termination Date: 10/14/2022
Review Date: 1/13/2020
Presenter
  • Elizabeth Stier, MD
    Associate Professor, Obstetrics and Gynecology
    Director, Dysplasia Services, Boston University Medical Center, Boston, MA
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Know the role of HPV testing in cervical cancer screening in women living with HIV (WLHIV).
  2. Appreciate the importance of recognizing vulvar and perianal intraepithelial neoplasm (VIN/PAIN) and associated treatment dilemmas.
  3. Understand how to screen for anal cancer in women-- who and how to screen.
Presenter Bio
Elizabeth Stier, MD
Elizabeth Stier, MD has lectured nationally and internationally on anal cancer prevention as well as evaluation of the cervix and vulva in women. She has a particular interest in multi-zonal disease in HIV-positive women and has led national multicenter studies investigating the diagnosis and treatment of HSIL of the cervix, vagina, vulva, peri-anus and anal canal. She has been co-chair of the HPV working group in the AIDS Malignancy Consortium (AMC) since 2001, the Boston PI for the ANCHOR study, co-chair of a randomized study of concurrent chemotherapy and pelvic radiation therapy in HIV-infected women, and also working on international AMC trials for the prevention and treatment of cervical cancer in in HIV-infected women in sub-Saharan Africa.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit on October 15, 2019 and will terminate October 14, 2022.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Elizabeth A. Stier, MD (Presenter) had no relevant financial relationships to disclose. Dr. Stier submitted her slides in advance for adequate peer review, and will support her presentation and clinical recommendations with the best available evidence from the medical literature.

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Gilead Sciences, Janssen Therapeutics (a division of Janssen Products, LP), Merck & Co., and ViiV Healthcare.

Details: 

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules